World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
87
Citations
25686
World Ranking
13727
National Ranking
42

Pierce K. H. Chow publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Pierce K. H. Chow sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 387 publications — 36th percentile

36% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Pierce K. H. Chow D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Pierce K. H. Chow sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 87 D-Index — 34th percentile

34% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Pierce K. H. Chow is affiliated with Singapore General Hospital in Singapore and has a significant research output primarily focused on hepatology, oncology, and molecular biology. Their work addresses a range of topics including hepatocellular carcinoma treatment and prognosis, liver disease diagnosis and treatment, pancreatic and hepatic oncology research, cancer immunotherapy and biomarkers, cholangiocarcinoma and gallbladder cancer studies, immune cells in cancer, and hepatitis B virus studies.

Their recent publications include:

  • Onco-fetal Reprogramming of Endothelial Cells Drives Immunosuppressive Macrophages in Hepatocellular Carcinoma (2020, Cell)
  • Cross-tissue single-cell landscape of human monocytes and macrophages in health and disease (2021, Immunity)
  • Atezolizumab plus bevacizumab versus active surveillance in patients with resected or ablated high-risk hepatocellular carcinoma (IMbrave050): a randomised, open-label, multicentre, phase 3 trial (2023, The Lancet)
  • IMbrave 050: A Phase III Trial of Atezolizumab Plus Bevacizumab in High-Risk Hepatocellular Carcinoma after Curative Resection or Ablation (2020, Future Oncology)
  • APASL clinical practice guideline on hepatitis B reactivation related to the use of immunosuppressive therapy (2021, Hepatology International)

Frequent collaborators in their research include:

  • Brian K. P. Goh
  • Chung Yip Chan
  • Peng Chung Cheow
  • Alexander Yaw Fui Chung
  • London Lucien Ooi

Publications by Pierce K. H. Chow are often found in several key venues:

  • Journal of Hepatology
  • bioRxiv (Cold Spring Harbor Laboratory)
  • Annals of Oncology
  • The Lancet
  • Hepatology International

The scientist's principal areas of study cover broad medical disciplines with an emphasis on hepatology and oncology. Their focused subfields of study include:

  • Hepatology
  • Oncology
  • Molecular Biology
  • Epidemiology
  • Cancer Research

The main topics evolving in their research are:

  • Hepatocellular Carcinoma Treatment and Prognosis
  • Liver Disease Diagnosis and Treatment
  • Pancreatic and Hepatic Oncology Research
  • Cancer Immunotherapy and Biomarkers
  • Cholangiocarcinoma and Gallbladder Cancer Studies
  • Immune cells in cancer
  • Hepatitis B Virus Studies

Best Publications

  • Asian Pacific Association for the Study of the Liver consensus recommendations on hepatocellular carcinoma.

    Masao Omata;Laurentius A. Lesmana;Ryosuke Tateishi;Pei Jer Chen

  • Whole-Genome and Epigenomic Landscapes of Etiologically Distinct Subtypes of Cholangiocarcinoma

    Apinya Jusakul;Apinya Jusakul;Ioana Cutcutache;Chern Han Yong;Jing Quan Lim

  • Onco-fetal Reprogramming of Endothelial Cells Drives Immunosuppressive Macrophages in Hepatocellular Carcinoma

    Ankur Sharma;Justine Jia Wen Seow;Charles-Antoine Dutertre;Rhea Pai

  • Cross-tissue single-cell landscape of human monocytes and macrophages in health and disease.

    Kevin Mulder;Kevin Mulder;Kevin Mulder;Amit Ashok Patel;Amit Ashok Patel;Wan Ting Kong;Cécile Piot

  • SIRveNIB: Selective Internal Radiation Therapy Versus Sorafenib in Asia-Pacific Patients With Hepatocellular Carcinoma

    Pierce K.H. Chow;Mihir Gandhi;Say Beng Tan;Maung Win Khin

  • Tumor cells disseminate early, but immunosurveillance limits metastatic outgrowth, in a mouse model of melanoma

    Jo Eyles;Anne Laure Puaux;Xiaojie Wang;Benjamin Toh

  • Exome sequencing identifies distinct mutational patterns in liver fluke–related and non-infection-related bile duct cancers

    Waraporn Chan-on;Waraporn Chan-on;Maarja-Liisa Nairismägi;Choon Kiat Ong;Weng Khong Lim

  • Management of hepatocellular carcinoma in Asia: consensus statement from the Asian Oncology Summit 2009

    Donald Poon;Benjamin O Anderson;Li-Tzong Chen;Koichi Tanaka

  • Microvascular invasion is a better predictor of tumor recurrence and overall survival following surgical resection for hepatocellular carcinoma compared to the Milan criteria.

    Kheng-Choon Lim;Pierce Kah-Hoe Chow;John C. Allen;Ghim-Song Chia

  • Interaction between tumour-infiltrating B cells and T cells controls the progression of hepatocellular carcinoma

    Marta Garnelo;Alex Tan;Zhisheng Her;Joe Yeong;Joe Yeong

  • Perforation of the Gastrointestinal Tract Secondary to Ingestion of Foreign Bodies

    Brian K.P. Goh;Pierce K.H. Chow;Hak-Mien Quah;Hock-Soo Ong

  • Transferrin-conjugated magnetic silica PLGA nanoparticles loaded with doxorubicin and paclitaxel for brain glioma treatment.

    Yanna Cui;Qingxing Xu;Pierce Kah-Hoe Chow;Pierce Kah-Hoe Chow;Deping Wang

  • Multidimensional analyses reveal distinct immune microenvironment in hepatitis B virus-related hepatocellular carcinoma

    Chun Jye Lim;Yun Hua Lee;Lu Pan;Liyun Lai

  • Critical appraisal of 232 consecutive distal pancreatectomies with emphasis on risk factors, outcome, and management of the postoperative pancreatic fistula: a 21-year experience at a single institution.

    Brian K. P. Goh;Yu-Meng Tan;Yaw-Fui Alexander Chung;Peng-Chung Cheow

  • Brivanib Alaninate, a Dual Inhibitor of Vascular Endothelial Growth Factor Receptor and Fibroblast Growth Factor Receptor Tyrosine Kinases, Induces Growth Inhibition in Mouse Models of Human Hepatocellular Carcinoma

    Hung Huynh;Van Chanh Ngo;Joseph Fargnoli;Mark Ayers

  • Lethal-7 is down-regulated by the hepatitis B virus x protein and targets signal transducer and activator of transcription 3

    Yu Wang;Yiwei Lu;Soo Ting Toh;Wing-Kin Sung;Wing-Kin Sung

  • High-dose tamoxifen in the treatment of inoperable hepatocellular carcinoma: A multicenter randomized controlled trial.

    Pierce K. H. Chow;Bee-Choo Tai;Chee-Kiat Tan;David Machin

  • An appraisal of surgical and percutaneous drainage for pyogenic liver abscesses larger than 5 cm.

    Yu-Meng Tan;Alexander Yaw-Fui Chung;Pierce Kah-Hoe Chow;Peng-Chung Cheow

  • CT in the preoperative diagnosis of fish bone perforation of the gastrointestinal tract

    Brian K P Goh;Yu-Meng Tan;Shueh-En Lin;Pierce K H Chow

  • A review of mucinous cystic neoplasms of the pancreas defined by ovarian-type stroma: clinicopathological features of 344 patients.

    Brian K. P. Goh;Yu-Meng Tan;Yaw-Fui A. Chung;Pierce K. H. Chow

Frequent Co-Authors

Patrick Tan
Patrick Tan Duke NUS Graduate Medical School
Florent Ginhoux
Florent Ginhoux Agency for Science, Technology and Research
Bin Tean Teh
Bin Tean Teh National University of Singapore
Chi-Hwa Wang
Chi-Hwa Wang National University of Singapore
Salvatore Albani
Salvatore Albani Duke NUS Graduate Medical School
Jerry Kok Yen Chan
Jerry Kok Yen Chan National University of Singapore
Wan Yee Lau
Wan Yee Lau Chinese University of Hong Kong
Kwang Hyub Han
Kwang Hyub Han Yonsei University
Annelies Wilder-Smith
Annelies Wilder-Smith University of Bern
Wing-Kin Sung
Wing-Kin Sung Chinese University of Hong Kong

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

If you're considering alternative routes into the medical field, there are several online programs and pathways to explore. For those without a nursing background, direct entry msn programs for non nurses online offer a fast-track option to earn a master's degree and transition into nursing.

Additionally, online adn programs for non nurses provide a more accessible route into nursing careers, particularly if you are looking to become a Registered Nurse without prior experience. Many students appreciate the flexibility and convenience of online studies as they balance other commitments.

Beyond nursing, medical billing and coding offers a strong career prospect within healthcare administration. Access to financial aid for medical billing and coding makes it easier for students to start their studies without worrying about upfront costs.

For those wanting to bypass certain admission hurdles, look into nursing school without teas test requirements. This can open doors to a wider range of candidates interested in healthcare careers.

Best Scientists Citing Pierce K. H. Chow

Trending Scientists

Recently Published Articles